Cubist Systematic Strategies, LLC Axogen, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 42,168 shares of AXGN stock, worth $640,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,168

Previous 143,613 70.64%

Holding current value

$640,110

Previous $2.01 Million 65.52%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$12.47 - $17.19 $1.27 Million - $1.74 Million	-101,445 Reduced 70.64%	42,168 $694,000
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $402,477 - $786,223	53,521 Added 59.41%	143,613 $2.01 Million
Q2 2024 Aug 14, 2024	SELL	$5.67 - $8.06 $165,189 - $234,820	-29,134 Reduced 24.44%	90,092 $652,000
Q1 2024 May 15, 2024	BUY	$6.63 - $10.69 $64,284 - $103,650	9,696 Added 8.85%	119,226 $962,000
Q4 2023 Feb 14, 2024	SELL	$3.61 - $7.76 $77,181 - $165,908	-21,380 Reduced 16.33%	109,530 $748,000
Q3 2023 Nov 14, 2023	BUY	$4.68 - $9.26 $496,430 - $982,254	106,075 Added 427.12%	130,910 $654,000
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $211,097 - $257,787	24,835 New	24,835 $226,000
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $161,603 - $224,087	17,119 Added 56.87%	47,219 $471,000
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $161,627 - $243,236	19,856 Added 193.83%	30,100 $359,000
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $242,469 - $346,880	-34,688 Reduced 77.2%	10,244 $84,000
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $32,176 - $47,422	4,432 Added 10.94%	44,932 $357,000
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $320,601 - $582,912	36,432 Added 895.58%	40,500 $379,000
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $15,077 - $21,502	-990 Reduced 19.57%	4,068 $64,000
Q2 2021 Aug 16, 2021	SELL	$17.8 - $23.5 $38,145 - $50,360	-2,143 Reduced 29.76%	5,058 $109,000
Q1 2021 May 17, 2021	BUY	$17.18 - $22.6 $43,018 - $56,590	2,504 Added 53.31%	7,201 $146,000
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $86,192 - $134,610	-7,495 Reduced 61.47%	4,697 $84,000
Q3 2020 Nov 16, 2020	SELL	$10.62 - $13.12 $191,000 - $235,963	-17,985 Reduced 59.6%	12,192 $142,000
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $123,480 - $181,608	16,800 Added 125.59%	30,177 $279,000
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $102,504 - $212,102	12,232 Added 1068.3%	13,377 $139,000
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $342,286 - $569,457	-30,616 Reduced 96.39%	1,145 $20,000
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $141,332 - $239,177	11,690 Added 58.24%	31,761 $396,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $256,151 - $352,657	13,846 Added 222.43%	20,071 $397,000
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $91,009 - $137,759	6,225 New	6,225 $131,000
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $42,968 - $70,880	-1,761 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $32,578 - $50,364	1,761	1,761 $50,000

Others Institutions Holding AXGN

# of Institutions

181

Shares Held

36.5M

Call Options Held

82.6K

Put Options Held

1.1K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $642M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Axogen, Inc. Transaction History